Icon plc Stock
With 1 Sell predictions and 1 Buy predictions the community sentiment towards the Icon plc stock is not clear.
With a current price of €176.00 Icon plc is right around the predicted target price of €175.00.
Pros and Cons of Icon plc in the next few years
Pros
Cons
Performance of Icon plc vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | -1.680% | 2.326% | 10.692% | 11.392% | 12.821% | 98.870% | 185.136% |
| Alkermes plc | -1.670% | -4.839% | -0.562% | 10.625% | 1.724% | - | - |
| Invitae Corp | -6.060% | 4.181% | 8.454% | 169.940% | 25.519% | - | - |
| Halozyme Therapeutics Inc. | -2.190% | 3.617% | 16.395% | 135.145% | 17.166% | - | - |
Other discussions about Icon plc Stock
New thread ForumNews
ICON plc to Present at the 39th Annual JP Morgan Healthcare Conference
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
ICON Releases First Environmental, Social and Governance Report
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
ICON plc to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference and Evercore ISI HealthCONx Conference
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
ICON plc to Present at Wells Fargo 2020 Virtual Global Healthcare Conference and Baird 2020 Global Healthcare Conference
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health
